Shuttle Pharmaceuticals ...

NASDAQ: SHPH · Real-Time Price · USD
3.38
-0.12 (-3.43%)
At close: Aug 15, 2025, 10:00 AM

Shuttle Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.92M 2.58M 8.42M 504.75K
Short-Term Investments
n/a 2.89M n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a 6.48K 6.48K
Receivables
n/a 14.9K n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
2.21M 5.59M 8.58M 509.62K
Property-Plant & Equipment
295.37K 358.73K 68.71K 135.55K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
295.37K 358.73K 75.19K 142.03K
Total Assets
2.51M 5.95M 8.65M 651.64K
Account Payables
596.6K 283.31K 129.25K 828.31K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
874.48K 596K 685.47K 849.5K
Other Current Liabilities
n/a n/a n/a 94.03K
Total Current Liabilities
1.53M 1.04M 975.68K 2.22M
Long-Term Debt
n/a 135.09K n/a n/a
Other Long-Term Liabilities
25.28K 414.51K n/a n/a
Total Long-Term Liabilities
263.37K 853.73K 865.04K 62.44K
Total Liabilities
1.8M 1.9M 975.68K 2.28M
Total Debt
1.17M 1.09M 748.3K 978.88K
Common Stock
41.00 20.00 17.00 93.00
Retained Earnings
-34.58B -25.43M -18.84M -5.8M
Comprehensive Income
n/a n/a n/a 16.34K
Shareholders Equity
709.15K 4.06M 7.68M -1.63M
Total Investments
n/a 2.89M n/a n/a